期刊文献+

间质性肺疾病的病因诊断 被引量:1

间质性肺疾病的病因诊断
原文传递
导出
摘要 1 间质性肺疾病的定义 肺间质为肺内支持结构,包括支气管、血管、淋巴管及肺内所有间隙内结缔组织。间质性肺疾病(interstitial lung disease,ILD)是异源性疾病。其临床、影像学以及病理表现类似,共同病理表现为肺间质炎症,可完全或部分消失,或发展为纤维化。
作者 赵顺英
出处 《中国实用儿科杂志》 CSCD 北大核心 2010年第6期417-418,共2页 Chinese Journal of Practical Pediatrics
关键词 间质性肺疾病 儿童 interstitial lung disease children
作者简介 赵顺英,医学博士。现为首都医科大学附属北京儿童医院副主任医师。为中华医学会儿科学分会呼吸学组秘书。目前主要从事哮喘发病机制的研究。发表专业论文20余篇。主要研究方向:儿童呼吸道疾病的诊治。电子信箱:zhaoshunying2001@yahoo.com.cn.
  • 相关文献

参考文献15

  • 1American Thoracic Society/European Respiratory Society. International multidisciplinary consensus classification of the idio- pathic interstitial pneumonias [J]. Am J Respir Crit Care Med, 2002,165 : 277-304.
  • 2Hilman BC. Diagnosis and treatment of ILD [ J ]. Pediatr Pulmonol, 1997,23:1-7.
  • 3Hilman BC, Amaro-Galvez R. Diagnosis of interstitial lung disease in children[J]. Paediatr Respir Rev, 2004 , 5:101-107.
  • 4Dinwiddie R, Sharief N, Crawford O. Idiopathic interstitial pneumonitis in children: a national survey in the United Kingdom and Ireland [ J ]. Pediatr Pulmonol, 2002,34 ( 1 ) : 23-29.
  • 5Fan LL, Deterding RR, Langston C. Pediatric interstitial lung disease revisited[J ]. Pediatr Pulmonol, 2004,38: 369-378.
  • 6Fan L, Langston C. Pediatric interstitial lung disease. Children are not small adults [J ]. Am J Respir Crit Care Med, 2002, 165: 1466-1467.
  • 7Frosch M, Foell D. Wegener granulomatosis in childhood and adolescence [ J ]. Eur J Pediatr, 2004,163 : 425-434.
  • 8Pfleger A, Eber E, Popper H, et al. Chronic interstitial lung dis- ease due to Epstein-Barr virus infection in two infants [J]. Eur. Respir J, 2000,15 : 803-806.
  • 9Vijayasekaran D, Giridhar S, Gowrishankar NC. Pediatric interstitial lung disease[J]. Indian Pediatr, 2006,43 : 899-903.
  • 10Deterding R. Evaluating infants and children with interstitial lung disease [J]. Semin Respir Crit Care Med, 2007, 28: 333-341.

二级参考文献8

  • 1翟昭华 周润发 主编.肺弥漫结节性疾病[A].周润发,主编.胸部X线?CT?MRI诊断学.第2版[C].北京:科学出版社,2000.386-420.
  • 2Fishman AP, Elias JA, Fishman JA, et al. Fisaman's pulmonary disease and disorders. 3rd ed. New York: McGaw-Hill, 2001.1037-1048.
  • 3Fan LL, Mullen ALM, Brugman SM, et al. Clinical spectrum of chronic interstitial lung diseases in children. J Pediatr, 1992,121 :867-872.
  • 4Kuhlman JE. High-Resolution computed tomography in interstitial lung disease. Clin Pulm Med, 2001,8:134-146.
  • 5Copley S J, Padley SPG. High-Resolution CT of paediatric lung disease. Eur Radiol, 2001, 11:2564-2575.
  • 6Silver FN. Kuhn JP. Caffery's pediatric X-Ray diagnosis . 9th eds.Louis: Mosby, 1999. 522-524.
  • 7Fan LL, Langston C. Chronic interstitial lung disease in children.Pediatr Pulmonol, 1993, 16:184-196.
  • 8MillerWT MillerJrWT 贺莉 倪文玺 译.胸部X线阅片指南[M].天津:天津科技翻译出版公司,2001.2-29.

共引文献8

同被引文献44

  • 1蔡后荣.间质性肺疾病的临床治疗进展[J].临床内科杂志,2005,22(4):223-226. 被引量:12
  • 2董彦,魏路清.间质性肺疾病治疗现状[J].临床荟萃,2005,20(8):474-475. 被引量:2
  • 3杨超,夏永良,宋康.从痰从瘀论治肺纤维化[J].中医药学刊,2006,24(6):1061-1062. 被引量:28
  • 4黄玉芳,马承立,刘书盈.特发性肺纤维化的发病机制及抗凝治疗研究进展[J].山东医药,2006,46(34):77-78. 被引量:2
  • 5American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board ofdirectors,June 2001 and by the ERS Executive Committee, June 2001[J]. Am J Respir Crit Care Meal,2002,165(2) :277- 304.
  • 6Murray LA,Chen Q,Kramer MS,et al. TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P[J]. Int J Biochem Cell Biol,2011,43(1) : 154-162.
  • 7Raghu G,Collard HR, Egan J J, et al. An official ATS/ERS/ JRS/ALAT statement: idiopathic pulmonary fibrosis evidence-based guidelines for diagnosis and management[J]. Am J Respir Crit Care Med,2011,183(6) :788-824.
  • 8Fiorucci E, Lucantoni G, Paone G, et al. Colchicine, cyclophosphamide and prednisone in the treatment of mild- moderate idiopathic pulmonary fibrosis: comparison of three currently available therapeutic regimens[J]. Eur Rev Med Pharmacol Sci, 2008,12 (2) : 105-111.
  • 9Shimbori C,Shiota N, Okunishi H. Effects of montelukast, a cysteinyl-leukotriene type I receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice [J]. Eur J Pharmacol,2011,650(1) :424-430.
  • 10King TE J r, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis[J]. N Engl J Med,2014,370(22):2083-2092.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部